After a blazing week, Novavax (NVAX) takes over top spot in the COVID VACCINE INDEX with a 305% return since March 1, replacing Inovio (INO).
Total return on the 25 COVID VACCINE STOCKS since March is 67%.
A top Fidelity Healthcare sector investor is too smart to buy COVID VACCINE STOCKS:
He does suggest BioNTech over Moderna:
No comments:
Post a Comment